
Canopy Growth Corporation (CGC)
$
0.89
-0.03 (-3.37%)
Key metrics
Financial statements
Free cash flow per share
-0.2506
Market cap
223.5 Million
Price to sales ratio
0.8030
Debt to equity
0.3593
Current ratio
5.3377
Income quality
0.2405
Average inventory
104 Million
ROE
-0.5288
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Canopy Growth Corporation, along with its subsidiaries, is engaged in the production, distribution, and sale of cannabis and hemp-based products for both recreational and medical purposes, primarily across Canada, the United States, and Germany. The total costs and expenses for the company are $386,138,000.00 reflecting its overall spending during the fiscal year 2024. The company operates through two segments: Global Cannabis and Other Consumer Products, featuring an extensive range of offerings such as dried cannabis flower, extracts, concentrates, beverages, gummies, and vapes. It reported an income before tax of -$596,997,000.00 showcasing its pre-tax profitability. Additionally, the gross profit stands at $79,511,000.00 highlighting the company's profitability from core operations. The income before tax ratio is -2.22 reflecting the pre-tax margin, which is an important indicator of financial health. With strong brand presence under names such as Tweed, 7ACRES, DOJA, Martha Stewart CBD, and others, Canopy Growth Corporation was formerly known as Tweed Marijuana Inc. and changed its name in September 2015. Incorporated in 2009 and headquartered in Smiths Falls, Canada, the company remains a significant player in the cannabis sector. In the financial markets, the stock is affordable at $1.37 making it suitable for budget-conscious investors. Furthermore, the stock has a high average trading volume of 12,579,998.00 indicating strong liquidity that attracts active traders. With a market capitalization of $401,208,544.00 the company is classified as a small-cap player, positioning it uniquely within the industry. It is a key player in the cannabis industry, contributing significantly to the overall market landscape. Additionally, it belongs to the Healthcare sector, driving innovation and growth, which is essential for its competitive edge and future prospects.
Investing in Canopy Growth Corporation (CGC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Canopy Growth Corporation stock to fluctuate between $0.77 (low) and $2.38 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-03-27, Canopy Growth Corporation's market cap is $401,208,544, based on 449,080,528 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, Canopy Growth Corporation has a Lower Market-Cap, indicating a difference in performance.
To buy Canopy Growth Corporation (CGC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CGC. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Canopy Growth Corporation's last stock split was 1:10 on 2023-12-20.
Revenue: $268,995,000 | EPS: -$5.53 | Growth: -14.53%.
Visit https://www.canopygrowth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $198.50 (2021-08-10) | All-time low: $0.77 (2025-04-09).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

businesswire.com
SMITH FALLS, Ontario & TUTTLINGEN, Germany--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced the appointment of David Männer as Managing Director of Storz & Bickel, a subsidiary of Canopy Growth, effective April 1, 2026. Mr. Männer succeeds Jürgen Bickel, Storz & Bickel's Co-founder, who has decided to transition out of his role. Founded in 2001, Storz & Bickel has grown into a global leader in vaporization techn.

fool.com
These two companies are facing nearly insurmountable challenges. Their share prices could keep on dropping over the medium term.

fool.com
Canopy Growth is a marijuana stock trading around $1 a share. The company is acquiring another marijuana business in a cash-and-stock transaction.

fool.com
Marijuana stocks were all the rage a few years ago, but the excitement has faded. Canopy Growth, a major player, is still struggling to become sustainably profitable.

fool.com
Canopy Growth is a large marijuana company with an increasingly diversified business. It is also a money-losing penny stock.

fool.com
Canopy Growth has been a disaster of an investment. Overly aggressive expansion efforts, share dilution, and industry headwinds are to blame.

zacks.com
Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.76 per share a year ago.

zacks.com
In the most recent trading session, Canopy Growth Corporation (CGC) closed at $1.09, indicating a -1.8% shift from the previous trading day.
fool.com
Canopy Growth's stock has been in a seemingly endless tailspin in recent years. It has, however, had brief periods where it has rallied, sometimes even after earnings.

zacks.com
Canopy Growth Corporation (CGC) concluded the recent trading session at $1.14, signifying a -2.56% move from its prior day's close.
See all news